☆ 4.8 Letter

Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome

NEW ENGLAND JOURNAL OF MEDICINE (2020)

期刊

NEW ENGLAND JOURNAL OF MEDICINE

卷 383, 期 10, 页码 986-989

出版社

MASSACHUSETTS MEDICAL SOC

DOI: 10.1056/NEJMc2001362

关键词

-

类别

Medicine, General & Internal

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Immunology

JAK Inhibition in Aicardi-Goutieres Syndrome: a Monocentric Multidisciplinary Real-World Approach Study

Marie-Louise Fremond, Marie Hully, Benjamin Fournier, Remi Barrois, Romain Levy, Melodie Aubart, Martin Castelle, Delphine Chabalier, Clarisse Gins, Eugenie Sarda, Buthaina Al Adba, Sophie Couderc, Celine D' Almeida, Claire-Marine Berat, Chloe Durrleman, Caroline Espil, Laetitia Lambert, Cecile Meni, Maximilien Perivier, Pascal Pillet, Laura Polivka, Manuel Schiff, Calina Todosi, Florence Uettwiller, Alice Lepelley, Gillian I. Rice, Luis Seabra, Sylvia Sanquer, Anne Hulin, Claire Pressiat, Lauriane Goldwirt, Vincent Bondet, Darragh Duffy, Despina Moshous, Brigitte Bader-Meunier, Christine Bodemer, Florence Robin-Renaldo, Nathalie Boddaert, Stephane Blanche, Isabelle Desguerre, Yanick J. Crow, Benedicte Neven

Summary: This study reports a real-world approach study of JAK1/2 inhibition in 11 patients with AGS, showing clear improvements in certain systemic features but less conclusive results in neurological features. The data suggest that other treatment approaches are urgently required for the neurologic features of AGS, and early diagnosis and central nervous system penetration may be important factors determining the efficacy of therapy.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Opsoclonus-myoclonus in Aicardi-Goutieres syndrome

Salam Alburaiky, Russell C. Dale, Yanick J. Crow, Hannah F. Jones, Evangeline Wassmer, Isabelle Melki, Odile Boespflug-Tanguy, Jeremy Do Cao, Domitille Gras, Cynthia Sharpe

Summary: Aicardi-Goutieres syndrome (AGS) is a rare genetic neuroinflammatory disorder associated with Opsoclonus-myoclonus syndrome. Cases suggest that AGS should be considered in children presenting with opsoclonus-myoclonus, and a positive response to JAK1/2 inhibition was observed in two patients.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Heterozygous missense variant of the proteasome subunit β-type 9 causes neonatal-onset autoinflammation and immunodeficiency

Nobuo Kanazawa, Hiroaki Hemmi, Noriko Kinjo, Hidenori Ohnishi, Jun Hamazaki, Hiroyuki Mishima, Akira Kinoshita, Tsunehiro Mizushima, Satoru Hamada, Kazuya Hamada, Norio Kawamoto, Saori Kadowaki, Yoshitaka Honda, Kazushi Izawa, Ryuta Nishikomori, Miyuki Tsumura, Yusuke Yamashita, Shinobu Tamura, Takashi Orimo, Toshiya Ozasa, Takashi Kato, Izumi Sasaki, Yuri Fukuda-Ohta, Naoko Wakaki-Nishiyama, Yutaka Inaba, Kayo Kunimoto, Satoshi Okada, Takeshi Taketani, Koichi Nakanishi, Shigeo Murata, Koh-ichiro Yoshiura, Tsuneyasu Kaisho

Summary: Genetic variants of the PSMB9 gene can cause autoinflammatory/immune deficiency syndrome, with impaired proteasome activity and maturation, leading to distinct symptoms such as pulmonary hypertension in addition to classic autoinflammatory syndromes. A mouse model of this genetic variant replicates the proteasome defects and immunodeficiency observed in patients, highlighting the importance of proteasome-associated autoinflammatory syndromes with immunodeficiency (PRAAS-ID) as a separate disease category.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

STING inhibitors target the cyclic dinucleotide binding pocket

Ze Hong, Jiahao Mei, Chenhui Li, Guohui Bai, Munire Maimaiti, Haiyang Hu, Wenying Yu, Li Sun, Lele Zhang, Dan Cheng, Yixian Liao, Senlin Li, Yanping You, Hongbin Sun, Jing Huang, Xing Liu, Judy Lieberman, Chen Wang

Summary: A potent STING antagonist SN-011 has been identified through in silico docking, which locks STING in an open inactive conformation and inhibits interferon and inflammatory cytokine induction. This specific STING inhibitor shows promising potential for treating STING-driven autoimmune diseases.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Pediatrics

Analysis of clinical characteristics of children with Aicardi-Goutieres syndrome in China

Wei Wang, Ting-Yan He, Li-Ping Zou, Wen-Dao Li, Zhong-Xun Yu, Ming-Sheng Ma, Jun Yang, Hong-Mei Song

Summary: AGS is a systemic disease that can cause severe sequelae and mortality. Early onset of chilblain-like rash, intracranial calcification, leukodystrophy, dystonia, developmental delay, positive autoimmune antibodies, and elevated ISGs may indicate a diagnosis of AGS. Comprehensive assessment of vital organ function and symptomatic treatment are crucial.

WORLD JOURNAL OF PEDIATRICS (2022)

添加到收藏夹

Article Genetics & Heredity

Aicardi-Goutieres syndrome-associated gene SAMHD1 preserves genome integrity by preventing R-loop formation at transcription-replication conflict regions

Kiwon Park, Jeongmin Ryoo, Heena Jeong, Minsu Kim, Sungwon Lee, Sung-Yeon Hwang, Jiyoung Ahn, Doyeon Kim, Hyungseok C. Moon, Daehyun Baek, Kwangsoo Kim, Hye Yoon Park, Kwangseog Ahn

Summary: Mutations in SAMHD1 gene are a cause of Aicardi-Goutieres syndrome and are also associated with various types of tumors and malignancies. SAMHD1 resolves R-loops induced by transcription-replication conflicts, contributing to genome stability maintenance. Depletion of SAMHD1 leads to R-loop accumulation and DNA damage responses, while downregulation of SAMHD1 expression is linked to different cancer types and poor survival rate. Thus, SAMHD1 and R-loop may serve as novel diagnostic markers and targets in anti-cancer therapy.

PLOS GENETICS (2021)

添加到收藏夹

Article Immunology

Case report: Pneumocystis jirovecii pneumonia in a severe case of Aicardi-Goutieres syndrome with an IFIH1 gain-of-function mutation mimicking combined immunodeficiency

Mojca Zeleznik, Aneta Soltirovska Salamon, Marusa Debeljak, Ales Goropevsek, Natasa Sustar, Damjana Kljucevsek, Alojz Ihan, Tadej Avcin

Summary: Aicardi-Goutieres syndrome (AGS) is a progressive encephalopathy caused by mutations leading to overproduction of type I interferon (IFN). A gain-of-function (GOF) mutation in the IFIH1 gene causes AGS type 7 through activation of the JAK-STAT pathway. This case report describes an infant with recurrent infections and a GOF mutation in the IFIH1 gene who was treated with the JAK inhibitor baricitinib, effectively blocking IFN-alpha activation but not slowing the progression of neurological symptoms.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Pediatrics

Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib

Wei Wang, Wei Wang, Siming Peng, Sihao Gao, Meiying Quan, Lijuan Gou, Changyan Wang, Zhixing Sun, Zhuo Li, Dongmei Lian, Hongmei Song

Summary: This study describes a 7-year-old Chinese boy with Aicardi-Goutières syndrome (AGS) who showed improvement with treatment. The addition of tocilizumab may be a potential alternative therapeutic option for AGS.

PEDIATRIC RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Augmentation of Stimulator of Interferon Genes-Induced Type I Interferon Production in COPA Syndrome

Takashi Kato, Masaki Yamamoto, Yoshitaka Honda, Takashi Orimo, Izumi Sasaki, Kohei Murakami, Hiroaki Hemmi, Yuri Fukuda-Ohta, Kyoichi Isono, Saki Takayama, Hidenori Nakamura, Yoshiro Otsuki, Toshiaki Miyamoto, Junko Takita, Takahiro Yasumi, Ryuta Nishikomori, Tadashi Matsubayashi, Kazushi Izawa, Tsuneyasu Kaisho

Summary: A novel COPA variant, V242G, was identified in 4 patients from one family. Through analyzing the gene-targeted mouse model, it was demonstrated that this variant leads to the manifestation of interstitial lung disease and abnormal activation of the STING pathway, resulting in increased type I interferon production.

ARTHRITIS & RHEUMATOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Suppression of TREX1 deficiency-induced cellular senescence and interferonopathies by inhibition of DNA damage response

Hekang Du, Nanyang Xiao, Sitong Zhang, Xueyuan Zhou, Yangfan Zhang, Zengzeng Lu, Yuqian Fu, Miaohui Huang, Shan Xu, Qi Chen

Summary: Mutations in the TREX1 gene can lead to cellular senescence and contribute to the development of type I interferonopathies and lupus-like diseases. This study identifies the involvement of DNA damage and the cGAS-STING and DNA damage response pathways in cellular senescence induced by TREX1 deletion. Inhibition of the DNA damage response can partially alleviate disease progression and may guide the development of targeted therapeutics.

ISCIENCE (2023)

添加到收藏夹

Article Neurosciences

Subacute Partially Reversible Leukoencephalopathy Expands the Aicardi-Goutieres Syndrome Phenotype

Isabella Peixoto de Barcelos, Clarissa Bueno, Luis Filipe S. Godoy, Andre Pessoa, Larissa A. Costa, Fernanda C. Monti, Katiane Souza-Cabral, Clarice Listik, Diego Castro, Bruno Della-Ripa, Fernando Freua, Lais C. Pires, Lia T. Kruger, Jose Luiz D. Gherpelli, Flavia B. Piazzon, Fabiola P. Monteiro, Leandro T. Lucato, Fernando Kok

Summary: This study reports a series of atypical presentations of Aicardi-Goutieres syndrome, including subacute loss of developmental milestones and regression of communication abilities. The patients showed improvement of lost abilities during follow-up but had residual spasticity and dysarthria. The findings expand the phenotype of AGS and highlight the importance of considering this syndrome in cases of subacute developmental regression. Rating: 9/10.

BRAIN SCIENCES (2023)

添加到收藏夹

Article Immunology

Characterization of a mutant samhd1 zebrafish model implicates dysregulation of cholesterol biosynthesis in Aicardi-Goutieres syndrome

Sarah E. Withers, Charlie F. Rowlands, Victor S. Tapia, Frances Hedley, Ioana-Emilia Mosneag, Siobhan Crilly, Gillian I. Rice, Andrew P. Badrock, Andrew Hayes, Stuart M. Allan, Tracy A. Briggs, Paul R. Kasher

Summary: Aicardi-Goutieres syndrome (AGS) is a genetic encephalopathy characterized by excessive type I interferon (IFN-I) activity and upregulation of IFN-stimulated genes (ISGs). Zebrafish were investigated as an alternative model for studying AGS and a mutant zebrafish line recapitulating AGS5 was generated. The homozygous mutant zebrafish larvae exhibited neurological phenotypes, increased expression of ISGs, brain cell death, microcephaly, and locomotion deficits. Dysregulation of cholesterol biosynthesis was also observed in the zebrafish model and AGS patient whole blood, suggesting a potential role of cholesterol dysregulation in AGS pathophysiology.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Goutieres syndrome

Jessica Galli, Marco Cattalini, Erika Loi, Rosalba Monica Ferraro, Silvia Giliani, Simona Orcesi, Lorenzo Pinelli, Raffaele Badolato, Elisa Fazzi

Summary: Baricitinib, a JAK-inhibitor, appears to improve symptoms in a child with Aicardi-Goutieres syndrome (AGS), reducing interferon levels and leading to recovery in cognitive, communicative, and relational skills, while the gross motor deficit persists.

CLINICAL CASE REPORTS (2023)

添加到收藏夹

Review Immunology

The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways

Taisuke Nakahama, Yukio Kawahara

Summary: ADAR1 is an RNA-editing enzyme that catalyzes adenosine-to-inosine conversions in dsRNAs. The p150 isoform of ADAR1 prevents MDA5 sensing of endogenous dsRNAs through its Zα domain and RNA-editing activity. ADAR1 also prevents ZBP1 sensing of Z-RNA and PKR sensing of right-handed dsRNAs.

INTERNATIONAL IMMUNOLOGY (2023)

添加到收藏夹

Article Pediatrics

Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation

Marco Cattalini, Jessica Galli, Fiammetta Zunica, Rosalba Monica Ferraro, Marialuisa Carpanelli, Simona Orcesi, Giovanni Palumbo, Lorenzo Pinelli, Silvia Giliani, Elisa Fazzi, Raffaele Badolato

Summary: Treatment with JAK inhibitor ruxolitinib in Aicardi-Goutieres Syndrome patients may improve neurological function, decrease type I interferon response, especially when started at early age in children.

FRONTIERS IN PEDIATRICS (2021)

添加到收藏夹

Article Genetics & Heredity

Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform

Guy Helman, Asako Takanohashi, Tracy L. Hagemann, Ming D. Perng, Marzena Walkiewicz, Sarah Woidill, Sunetra Sase, Zachary Cross, Yangzhu Du, Ling Zhao, Amy Waldman, Bret C. Haake, Ali Fatemi, Michael Brenner, Omar Sherbini, Albee Messing, Adeline Vanderver, Cas Simons

HUMAN MUTATION (2020)

添加到收藏夹

Article Biology

TUBB4A mutations result in both glial and neuronal degeneration in an H-ABC leukodystrophy mouse model

Sunetra Sase, Akshata A. Almed, C. Alexander Boecker, Pedro Guedes-Dias, Jian J. Li, Asako Takanohashi, Akshilkumar Patel, Tara McCaffrey, Heta Pater, Divya Sirdeshpande, Julian Culler, Judy Shih-Hwa Liu, Quasar Padiath, Erika L. F. Holzbaur, Steven S. Scherer, Adeline Vanderver

ELIFE (2020)

添加到收藏夹

Article Genetics & Heredity

Assessing non-Mendelian inheritance in inherited axonopathies

Dana M. Bis-Brewer, Ziv Gan-Or, Patrick Sleiman, Hakon Hakonarson, Sarah Fazal, Steve Courel, Vivian Cintra, Feifei Tao, Mehrdad A. Estiar, Mark Tarnopolsky, Kym M. Boycott, Grace Yoon, Oksana Suchowersky, Nicolas Dupre, Andrew Cheng, Thomas E. Lloyd, Guy Rouleau, Rebecca Schuele, Stephan Zuchner

GENETICS IN MEDICINE (2020)

添加到收藏夹

Article Clinical Neurology

Clinical Course in a Patient With Spinal Muscular Atrophy Type 0 Treated With Nusinersen and Onasemnogene Abeparvovec

Susan E. Matesanz, Candace Curry, Brianna Gross, Adam I. Rubin, Rebecca Linn, Sabrina W. Yum, Elizabeth A. Kichula

JOURNAL OF CHILD NEUROLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS

Kayla M. D. Cornett, Manoj P. Menezes, Paula Bray, Rosemary R. Shy, Isabella Moroni, Emanuela Pagliano, Davide Pareyson, Tim Estilow, Sabrina W. Yum, Trupti Bhandari, Francesco Muntoni, Matilde Laura, Mary M. Reilly, Richard S. Finkel, Katy J. Eichinger, David N. Herrmann, Michael E. Shy, Joshua Burns

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Cerebral Microangiopathy in Leukoencephalopathy With Cerebral Calcifications and Cysts: A Pathological Description

Guy Helman, Angela N. Viaene, Asako Takanohashi, Marjolein Breur, Rebecca Berger, Sarah Woidill, John R. Cottrell, Raphael Schiffmann, Yanick J. Crow, Cas Simons, Marianna Bugiani, Adeline Vanderver

Summary: Leukoencephalopathy with calcifications and cysts (LCC) is a neurological syndrome associated with pathogenic variants in SNORD118. Neuropathological findings in a genetically confirmed LCC individual revealed diffuse destructive process due to a vasculopathy with secondary ischemic lesions and mineralization. Treatment with Bevacizumab may offer clinical and radiological benefit for LCC patients, especially in cases where rapid diagnosis and trial of this treatment modality is considered appropriate.

JOURNAL OF CHILD NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy

Alistair T. Pagnamenta, Rauan Kaiyrzhanov, Yaqun Zou, Sahar Da, Reza Maroofian, Sandra Donkervoort, Natalia Dominik, Marlen Lauffer, Matteo P. Ferla, Andrea Orioli, Adam Giess, Arianna Tucci, Christian Beetz, Maryam Sedghi, Behnaz Ansari, Rita Barresi, Keivan Basiri, Andrea Cortese, Greg Elgar, Miguel A. Fernandez-Garcia, Janice Yip, A. Reghan Foley, Nicholas Gutowski, Heinz Jungbluth, Saskia Lassche, Tim Lavin, Carlo Marcelis, Peter Marks, Chiara Marini-Bettolo, Livija Medne, Ali-Reza Moslemi, Anna Sarkozy, Mary M. Reilly, Francesco Muntoni, Francisca Millan, Colleen C. Muraresku, Anna C. Need, Andrea H. Nemeth, Sarah B. Neuhaus, Fiona Norwood, O. Marie, Mary O'Driscoll, Julia Rankin, Sabrina W. Yum, Zarazuela Zolkipli-Cunningham, Isabell Brusius, Gilbert Wunderlich, Mert Karakaya, Brunhilde Wirth, Khalid A. Fakhro, Homa Tajsharghi, Carsten G. Bonnemann, Jenny C. Taylor, Henry Houlden

Summary: VWA1 gene plays a role in stabilizing extracellular matrix structures and is highly expressed in the tibial nerve; biallelic variants in VWA1 may cause non-length dependent hereditary motor neuropathy in Europeans, accounting for up to 1% of unexplained cases.

BRAIN (2021)

添加到收藏夹

Review Medicine, General & Internal

Acute flaccid myelitis: cause, diagnosis, and management

Olwen C. Murphy, Kevin Messacar, Leslie Benson, Riley Bove, Jessica L. Carpenter, Thomas Crawford, Janet Dean, Roberta DeBiasi, Jay Desai, Matthew J. Elrick, Raquel Farias-Moeller, Grace Y. Gombolay, Benjamin Greenberg, Matthew Harmelink, Sue Hong, Sarah E. Hopkins, Joyce Oleszek, Catherine Otten, Cristina L. Sadowsky, Teri L. Schreiner, Kiran T. Thakur, Keith Van Haren, Carolina M. Carballo, Pin Fee Chong, Amary Fall, Vykuntaraju K. Gowda, Jelte Helfferich, Ryutaro Kira, Ming Lim, Eduardo L. Lopez, Elizabeth M. Wells, E. Ann Yeh, Carlos A. Pardo

Summary: Acute flaccid myelitis (AFM) is a polio-like illness mainly affecting children, characterized by muscle weakness. Diagnosis relies on identification of various clinical, neuroimaging, and cerebrospinal fluid characteristics, with patients often experiencing residual disability and requiring long-term rehabilitation. Future research focuses on evaluating host and pathogen factors to improve long-term outcomes in this population.

LANCET (2021)

添加到收藏夹

Article Clinical Neurology

Hepatic Involvement in Aicardi-Goutieres Syndrome

Francesco Gavazzi, Zachary M. Cross, Sarah Woidill, Joseph M. McMann, Elizabeth B. Rand, Asako Takanohashi, Nicole Ulrick, Justine Shults, Adeline L. Vanderver, Laura Adang

Summary: Aicardi-Goutières syndrome (AGS) is a monogenic type-I interferonopathy that results in neurologic injury and is associated with liver inflammation. All genotypes of AGS are associated with transient elevations of liver enzymes and the presence of liver-associated autoantibodies.

NEUROPEDIATRICS (2021)

添加到收藏夹

Article Clinical Neurology

Disease-modifying effects of edasalonexent, an NF-KB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial

Richard S. Finkel, Erika Finanger, Krista Vandenborne, H. Lee Sweeney, Gihan Tennekoon, Perry B. Shieh, Rebecca Willcocks, Glenn Walter, William D. Rooney, Sean C. Forbes, William T. Triplett, Sabrina W. Yum, Maria Mancini, James MacDougall, Angelika Fretzen, Pradeep Bista, Andrew Nichols, Joanne M. Donovan

Summary: The study showed that edasalonexent could slow disease progression and preserve muscle function in boys with Duchenne muscular dystrophy, with no serious adverse events. These results support further investigation of edasalonexent in future trials.

NEUROMUSCULAR DISORDERS (2021)

添加到收藏夹

Article Clinical Neurology

Association Between Body Mass Index and Disability in Children With Charcot-Marie-Tooth Disease

Gabrielle A. Donlevy, Sarah P. Garnett, Kayla M. D. Cornett, Marnee J. McKay, Jennifer N. Baldwin, Rosemary R. Shy, Sabrina W. Yum, Timothy Estilow, Isabella Moroni, Maria Foscan, Emanuela Pagliano, Davide Pareyson, Matilde Laura, Trupti Bhandari, Francesco Muntoni, Mary M. Reilly, Richard S. Finkel, Janet E. Sowden, Katy J. Eichinger, David N. Herrmann, Michael E. Shy, Joshua Burns, Manoj P. Menezes

Summary: This study examined the relationship between body mass index (BMI) and disability in children with Charcot-Marie-Tooth disease (CMT). The results showed that compared to healthy children, children with CMT had a higher proportion of being severely underweight, underweight, and obese, while having a lower proportion of being at a healthy weight. Furthermore, being underweight or obese was associated with greater disability in children with CMT compared to those of a healthy weight.

NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease

Gabrielle A. Donlevy, Kayla M. D. Cornett, Sarah P. Garnett, Rosemary Shy, Timothy Estilow, Sabrina W. Yum, Kimberly Anderson, Davide Pareyson, Isabella Moroni, Francesco Muntoni, Mary M. Reilly, Richard S. Finkel, David N. Herrmann, Katy J. Eichinger, Michael E. Shy, Joshua Burns, Manoj P. Menezes

Summary: This study aimed to evaluate the impact of body mass index (BMI) on disease progression in children with Charcot-Marie-Tooth disease (CMT) over a period of 2 years. The results showed that children with CMT who were underweight or obese exhibited greater disability. It suggests that interventions to maintain or improve BMI towards a healthy weight may reduce disability in children with CMT.

NEUROLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Macrophage depletion blocks congenital SARM1-dependent neuropathy

Caitlin B. Dingwall, Amy Strickland, Sabrina W. Yum, Aldrin K. Y. Yim, Jian Zhu, Peter L. Wang, Yurie Yamada, Robert E. Schmidt, Yo Sasaki, A. Joseph Bloom, Aaron DiAntonio, Jeffrey Milbrandt

Summary: This study identified rare NMNAT2 gene variants associated with a neuropathy syndrome and demonstrated the importance of SARM1-related neuroimmune mechanisms in disease pathogenesis. Macrophage depletion therapy was shown to block and reverse neuropathic phenotypes in mice with NMNAT2 mutations.

JOURNAL OF CLINICAL INVESTIGATION (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.